Assessment of Mixed <i>Plasmodium falciparum</i> <i>sera5</i> Infection in Endemic Burkitt Lymphoma: A Case-Control Study in Malawi

Background: Endemic Burkitt lymphoma (eBL) is the most common childhood cancer in Africa and is linked to <i>Plasmodium falciparum</i> (<i>Pf</i>) malaria infection, one of the most common and deadly childhood infections in Africa; however, the role of <i>Pf</i> g...

Full description

Bibliographic Details
Main Authors: Nobuko Arisue, George Chagaluka, Nirianne Marie Q. Palacpac, W. Thomas Johnston, Nora Mutalima, Sally Peprah, Kishor Bhatia, Eric Borgstein, George N. Liomba, Steve Kamiza, Nyengo Mkandawire, Collins Mitambo, James J. Goedert, Elizabeth M. Molyneux, Robert Newton, Toshihiro Horii, Sam M. Mbulaiteye
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/7/1692
Description
Summary:Background: Endemic Burkitt lymphoma (eBL) is the most common childhood cancer in Africa and is linked to <i>Plasmodium falciparum</i> (<i>Pf</i>) malaria infection, one of the most common and deadly childhood infections in Africa; however, the role of <i>Pf</i> genetic diversity is unclear. A potential role of <i>Pf</i> genetic diversity in eBL has been suggested by a correlation of age-specific patterns of eBL with the complexity of <i>Pf</i> infection in Ghana, Uganda, and Tanzania, as well as a finding of significantly higher <i>Pf</i> genetic diversity, based on a sensitive molecular barcode assay, in eBL cases than matched controls in Malawi. We examined this hypothesis by measuring diversity in <i>Pf-</i>serine repeat antigen-5 (<i>Pfsera5</i>), an antigenic target of blood-stage immunity to malaria, among 200 eBL cases and 140 controls, all <i>Pf</i> polymerase chain reaction (PCR)-positive, in Malawi. Methods: We performed <i>Pfsera5</i> PCR and sequencing (~3.3 kb over exons II–IV) to determine single or mixed <i>Pf</i>SERA5 infection status. The patterns of <i>Pfsera5</i> PCR positivity, mixed infection, sequence variants, and haplotypes among eBL cases, controls, and combined/pooled were analyzed using frequency tables. The association of mixed <i>Pfsera5</i> infection with eBL was evaluated using logistic regression, controlling for age, sex, and previously measured <i>Pf</i> genetic diversity. Results: <i>Pfsera5</i> PCR was positive in 108 eBL cases and 70 controls. Mixed <i>Pf</i>SERA5 infection was detected in 41.7% of eBL cases versus 24.3% of controls; the odds ratio (OR) was 2.18, and the 95% confidence interval (CI) was 1.12–4.26, which remained significant in adjusted results (adjusted odds ratio [aOR] of 2.40, 95% CI of 1.11–5.17). A total of 29 nucleotide variations and 96 haplotypes were identified, but these were unrelated to eBL. Conclusions: Our results increase the evidence supporting the hypothesis that infection with mixed <i>Pf</i> infection is increased with eBL and suggest that measuring <i>Pf</i> genetic diversity may provide new insights into the role of <i>Pf</i> infection in eBL.
ISSN:2072-6694